-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Axsome Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2024.
- Axsome Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -290 %, a 158% decline year-over-year.
- Axsome Therapeutics, Inc. annual Return On Equity for 2024 was -290 %, a 158% decline from 2023.
- Axsome Therapeutics, Inc. annual Return On Equity for 2023 was -112 %, a 55.4% increase from 2022.
- Axsome Therapeutics, Inc. annual Return On Equity for 2022 was -252 %, a 9.31% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)